ÌÇÐÄlogo

Akash J. Patel

Patel

Akash J. Patel, M.D.

Ruth Mitzner Professor in Neurosurgery

(713) 798-4696

Positions

Ruth Mitzner Professor in Neurosurgery
Neurosurgery
ÌÇÐÄlogo
Houston, TX, US
Member
Dan L Duncan Comprehensive Cancer Center
ÌÇÐÄlogo
Houston, Texas, United States
Professor (Joint Appointment)
Department of Otolaryngology – Head & Neck Surgery
ÌÇÐÄlogo
Houston, Texas, United States
Residency Program Director
Neurosurgery
ÌÇÐÄlogo
Houston, Texas, United States
Director of Brain Tumor Surgery
Neurosurgery
ÌÇÐÄlogo
Houston, Texas, United States

Addresses

ÌÇÐÄlogo St. Luke's McNair Campus (Clinic)
7200 Cambridge
9th Floor
Houston, TX, 77030
United States
Phone: (713) 798-4696
ÌÇÐÄlogo St. Luke's McNair Campus (Office)
7200 Cambridge
9th Floor
Houston, TX, 77030
United States
Phone: (713) 798-4696

Education

BA from Rice University
Houston, Texas, United States
Biochemistry
MD from ÌÇÐÄlogo
Houston, Texas, United States
Residency at ÌÇÐÄlogo
Houston, Texas, United States

Certifications

Diplomate
American Board of Neurological Surgeons

Honors & Awards

Educator of the Year (2021)
Congress of Neurological Surgeons
Christopher C. Getch Fellowship (2015)
Congress of Neurological Surgeons
Leadership Fellow, CNS Leadership Institute (2017)
Congress of Neurological Surgeons
Elected to the Society of Neurological Surgeons (2023)
Society of Neurological Surgeons
Vanguard Leadership in Health Care, CNS Leadership Institute (2026)
Congress of Neurological Surgeons
Elected to the American Academy of Neurological Surgery (2026)
American Academy of Neurological Surgery

Professional Interests

  • Open and endoscopic surgery for malignant and benign brain tumors
  • Skull base tumors
  • Meningiomas, acoustic neuromas, glioblastomas
  • Brain tumor surgery in deep and eloquent brain regions
  • Surgery and genetics of meningiomas and schwannomas
  • Neurofibromatosis

Professional Statement

Dr. Patel is a board-certified neurosurgeon specializing in brain and skull base tumors, with particular expertise in meningiomas and vestibular schwannomas (acoustic neuromas). He provides individualized care through careful evaluation, advanced microsurgical techniques, and multidisciplinary collaboration. His NIH-funded laboratory studies the molecular biology of meningiomas to understand why they form, grow, and recur, with the goal of identifying new treatments.

Websites

Independent professional website of Dr. Patel, with clinical, research, and consultation information.
Publications and citations on Google Scholar.
Public bibliography of peer-reviewed publications.

Videos

Dr. Patel discusses collaboration in neurosurgery and how his laboratory uses machine learning and AI to study meningioma biology and molecular classification.

Selected Publications

  • Bayley JC V, Hadley CC, Harmanci AO, Harmanci AS, Klisch TJ, Patel AJ. " " Sci Adv. 2022 Feb 4; 8 (5)
    Pubmed PMID: .
  • Jackson HN, Hadley CC, Khan AB, Gadot R, Bayley JC V, Shetty A, Mandel J, Jalali A, Gallagher KK, Sweeney AD, Harmanci AO, Harmanci AS, Klisch TJ, Gopinath SP, Rao G, Yoshor D, Patel AJ. " " Neurosurgery. 2022 Jan 1; 90 (1) : 114-123.
    Pubmed PMID: .
  • Patel AJ, Wan YW, Al-Ouran R, Revelli JP, Cardenas MF, Oneissi M, Xi L, Jalali A, Magnotti JF, Muzny DM, Doddapaneni H, Sebastian S, Heck KA, Goodman JC, Gopinath SP, Liu Z, Rao G, Plon SE, Yoshor D, Wheeler DA, Zoghbi HY, Klisch TJ. " " Proc Natl Acad Sci U S A. 2019 Oct 22; 116 (43) : 21715-21726.
    Pubmed PMID: .
  • Patel AJ, Suki D, Hatiboglu M, Rao VY, Fox BD, Sawaya R. " " J Neurosurg. 2015 Mar 20; 1-12.
    Pubmed PMID: .

Projects

GammaTile Surgically Targeted Radiation Therapy (STaRT) in Intracranial Brain Neoplasms (GTM-101)
GT Medical Technologies, Inc.
ÌÇÐÄlogo, Houston, TX
Site Principal Investigator, ÌÇÐÄlogo (2023-present). Multicenter observational study of GammaTile Surgically Targeted Radiation Therapy (STaRT) in intracranial brain neoplasms.
ROADS: Post-Surgical Stereotactic Radiotherapy versus GammaTile for Newly Diagnosed Metastatic Brain Tumors (GTM-102)
GT Medical Technologies, Inc.
ÌÇÐÄlogo, Houston, TX
Site Principal Investigator, ÌÇÐÄlogo (2024-2025). Phase 3 randomized controlled trial of post-surgical stereotactic radiotherapy (SRT) versus Surgically Targeted Radiation Therapy with GammaTile for newly diagnosed metastatic brain tumors.
Single-Fraction versus Fractionated Post-Surgical Stereotactic Radiosurgery for Resected Brain Metastases (Alliance A071801)
Alliance for Clinical Trials in Oncology
ÌÇÐÄlogo, Houston, TX
Site Principal Investigator, ÌÇÐÄlogo (2021-2022). Phase III trial comparing post-surgical single-fraction stereotactic radiosurgery (SRS) with fractionated SRS for resected metastatic brain disease.

Memberships

Congress of Neurological Surgeons
Executive Committee; 2027 Annual Meeting Chair; Education Committee Chair & Senior Advisor (01/2007)
American Association of Neurological Surgeons
Fellow (01/2007)
Texas Association of Neurological Surgeons
Vice President (01/2008)
North American Skull Base Society
Member (01/2017)
American Academy of Neurological Surgery
Member
Society of Neurological Surgeons
Executive Council; Chair, Medical Student Committee
American Association of South Asian Neurosurgeons
Secretary
AANS/CNS Section on Tumors
Executive Committee; Education Subcommittee

Funding

Establishing the Genomic Landscape of Human Atypical Meningiomas
#K08NS102474
(07/01/2017 - 06/30/2022)
Grant funding from NIH
Understanding the Epigenetic Drivers of Gene Expression Subtypes of Human Meningiomas
#19RDM005
(11/01/2019 - 12/01/2020)
Grant funding from Roderick D. MacDonald Research Grant
Establishing the Genomic Landscape of Human Atypical Meningiomas
#16RDM004
(01/01/2017 - 12/31/2017)
Grant funding from Roderick D. MacDonald Research Grant
Decoding Cellular Heterogeneity of Malignant Glioma
#5-RP160192
(07/01/2015 - 06/01/2018)
Grant funding from Cancer Prevention & Research Institute of Texas
Identifying the Biological Determinants of Aggressive Meningioma
#RP240263
Grant funding from Cancer Prevention & Research Institute of Texas (CPRIT)
Principal Investigator (2024-2027)
Harnessing Anti-Meningioma Immunity
#NW 73990-I
Grant funding from Helis Medical Research Foundation
Co-Principal Investigator (2024-2027)
Genomic and Biochemical Mechanisms Underlying Meningioma Race Disparity Across Social and Structural Drivers of Health
#1U54CA302452-01
Grant funding from National Cancer Institute (NCI)
Co-Investigator (PI: David Raleigh) (2025-2030)

Intellectual Property

Systems and Methods for Identifying Molecular Groups of Meningioma Using Radiographic and Radiomic Features
Method Patent (Pending)
Patent application filed June 2024.
Co Inventors: Tiemo Klisch

Languages

Gujarati

to edit your profile